EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Maximising the potential of type 2 diabetes remission: scale up and sustainability considerations from the DiRECT-Aus implementation trial

Nilakshi Gunatillaka, Jenny Advocat, Lauren Ball, Terry Haines, Cylie Williams, Tze Lin Chai, Mitchell Bowden, Melissa Savaglio, Kate Gudorf, Elizabeth Sturgiss

Australian Journal of Primary Health · 11.04.2025 · 31 (2)

DOI: 10.1071/py24116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian Journal of Primary Health, online erschienen am 03.03.2025. Verfasst von Nilakshi Gunatillaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Primary and Allied Health Care, Monash University, Melbourne, Vic 3199, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Western NSW Primary Health Network, Healthy North Coast (North Coast PHN), Southwestern Sydney PHN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 500 million people worldwide live with type 2 diabetes mellitus. The UK’s ‘Diabetes Remission Clinical Trial’ (DiRECT) is a potential novel method for care. An Australian trial of DiRECT (DiRECT-Aus) showed that 56% of participants achieved diabetes remission at 12 months. We explored the experiences of patients, clinicians and trial partners involved in DiRECT-Aus to ascertain the acceptability and feasibility of DiRECT-Aus, as well as factors influencing implementation, to inform recommendations for sustainable scale up into mainstream primary care.

Methods

This qualitative implementation research conducted within a constructivist paradigm involved semi-structured interviews with key stakeholders. Data analysis followed an inductive thematic approach, informed by the Consolidated Framework for Implementation Research.

Results

Patients (n = 14), general practitioners (n = 3), practice nurses (n = 6), dietitians (n = 7) and DiRECT-Aus trial partners (n = 5) were interviewed. We identified four core components of DiRECT-Aus that are essential for implementation and scale up. They were: (1) access to very low-energy diet products; (2) high frequency of contact with the dietitian; (3) dietitian’s clinical knowledge and patient-centred practice; and (4) absence of financial costs to patients. Several additional factors that could support implementation and suggested funding models are described.

Conclusions

This study concludes that DiRECT-Aus was acceptable and feasible to patients and clinicians.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HumansQualitative ResearchAustraliaFemaleMaleMiddle AgedRemission InductionPrimary Health CareInterviews as Topic

Autor:innen und Institutionen

  • School of Primary and Allied Health Care, Monash University, Melbourne, Vic 3199, Australia.
  • Centre for Community Health and Wellbeing, The University of Queensland, Brisbane, Qld 4072, Australia.
  • Health and Social Care Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic 3141, Australia.
  • Diabetes Australia, Sydney, NSW 2037, Australia; and Western Sydney Primary Health Network, Sydney, NSW 2560, Australia.

Förderung

  • Western NSW Primary Health Network
  • Healthy North Coast (North Coast PHN)
  • Southwestern Sydney PHN
  • Sydney North Health Network
  • Diabetes Australia
  • Western Sydney Primary Health Network

Zitieren

APA

Gunatillaka, N., Advocat, J., Ball, L., Haines, T., Williams, C., Chai, T. L., Bowden, M., Savaglio, M., Gudorf, K., & Sturgiss, E. (2025). Maximising the potential of type 2 diabetes remission: scale up and sustainability considerations from the DiRECT-Aus implementation trial. Australian Journal of Primary Health, 31(2). https://doi.org/10.1071/py24116

Vancouver

Gunatillaka N, Advocat J, Ball L, Haines T, Williams C, Chai TL, et al. Maximising the potential of type 2 diabetes remission: scale up and sustainability considerations from the DiRECT-Aus implementation trial. Australian Journal of Primary Health. 2025;31(2). doi:10.1071/py24116

BibTeX
@article{Gunatillaka2025,
  author = {Gunatillaka, Nilakshi and Advocat, Jenny and Ball, Lauren and Haines, Terry and Williams, Cylie and Chai, Tze Lin and Bowden, Mitchell and Savaglio, Melissa and Gudorf, Kate and Sturgiss, Elizabeth},
  title = {Maximising the potential of type 2 diabetes remission: scale up and sustainability considerations from the DiRECT-Aus implementation trial},
  journal = {Australian Journal of Primary Health},
  year = {2025},
  volume = {31},
  number = {2},
  doi = {10.1071/py24116}
}
Kostenlos starten →